The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Viral Testing Market Research Report 2024
Synopsis
It is the process of analyzing virus contamination by querying samples of body fluids, hemoglobin or socially infected areas, and analyzing under the guidance of an electronic oscilloscope.
The global Viral Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Viral Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Viral Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Viral Testing in Laboratory is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Viral Testing include Roche, Agilent Technologies, Thermo Fisher Scientific, QIAGEN International, Lonza, Wuxi Pharmatech (Cayman), Merck, Eurofins Scientific and General Electric, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Testing.
Report Scope
The Viral Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Agilent Technologies
Thermo Fisher Scientific
QIAGEN International
Lonza
Wuxi Pharmatech (Cayman)
Merck
Eurofins Scientific
General Electric
Danaher
Bio-Rad Laboratories
BD
Biospherix
Novogene Corporation
Sartorius
Segment by Type
Direct Fluorescent Antibody (DFA) Test
Immunochromatographic Assay
RT-PCR-Based Test
Agglutination Assay
Flow-Through Assay
Solid-Phase Assay
Segment by Application
Laboratory
Hospital
Home Care
Academic Institute
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
It is the process of analyzing virus contamination by querying samples of body fluids, hemoglobin or socially infected areas, and analyzing under the guidance of an electronic oscilloscope.
The global Viral Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Viral Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Viral Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Viral Testing in Laboratory is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Viral Testing include Roche, Agilent Technologies, Thermo Fisher Scientific, QIAGEN International, Lonza, Wuxi Pharmatech (Cayman), Merck, Eurofins Scientific and General Electric, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Viral Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Testing.
Report Scope
The Viral Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Viral Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Viral Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Agilent Technologies
Thermo Fisher Scientific
QIAGEN International
Lonza
Wuxi Pharmatech (Cayman)
Merck
Eurofins Scientific
General Electric
Danaher
Bio-Rad Laboratories
BD
Biospherix
Novogene Corporation
Sartorius
Segment by Type
Direct Fluorescent Antibody (DFA) Test
Immunochromatographic Assay
RT-PCR-Based Test
Agglutination Assay
Flow-Through Assay
Solid-Phase Assay
Segment by Application
Laboratory
Hospital
Home Care
Academic Institute
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Viral Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Viral Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Direct Fluorescent Antibody (DFA) Test
1.2.3 Immunochromatographic Assay
1.2.4 RT-PCR-Based Test
1.2.5 Agglutination Assay
1.2.6 Flow-Through Assay
1.2.7 Solid-Phase Assay
1.3 Market by Application
1.3.1 Global Viral Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Laboratory
1.3.3 Hospital
1.3.4 Home Care
1.3.5 Academic Institute
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Testing Market Perspective (2019-2030)
2.2 Viral Testing Growth Trends by Region
2.2.1 Global Viral Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Viral Testing Historic Market Size by Region (2019-2024)
2.2.3 Viral Testing Forecasted Market Size by Region (2025-2030)
2.3 Viral Testing Market Dynamics
2.3.1 Viral Testing Industry Trends
2.3.2 Viral Testing Market Drivers
2.3.3 Viral Testing Market Challenges
2.3.4 Viral Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Viral Testing Players by Revenue
3.1.1 Global Top Viral Testing Players by Revenue (2019-2024)
3.1.2 Global Viral Testing Revenue Market Share by Players (2019-2024)
3.2 Global Viral Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Viral Testing Revenue
3.4 Global Viral Testing Market Concentration Ratio
3.4.1 Global Viral Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Viral Testing Revenue in 2023
3.5 Viral Testing Key Players Head office and Area Served
3.6 Key Players Viral Testing Product Solution and Service
3.7 Date of Enter into Viral Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Viral Testing Breakdown Data by Type
4.1 Global Viral Testing Historic Market Size by Type (2019-2024)
4.2 Global Viral Testing Forecasted Market Size by Type (2025-2030)
5 Viral Testing Breakdown Data by Application
5.1 Global Viral Testing Historic Market Size by Application (2019-2024)
5.2 Global Viral Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Viral Testing Market Size (2019-2030)
6.2 North America Viral Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Viral Testing Market Size by Country (2019-2024)
6.4 North America Viral Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Viral Testing Market Size (2019-2030)
7.2 Europe Viral Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Viral Testing Market Size by Country (2019-2024)
7.4 Europe Viral Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Viral Testing Market Size (2019-2030)
8.2 Asia-Pacific Viral Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Viral Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Viral Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Viral Testing Market Size (2019-2030)
9.2 Latin America Viral Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Viral Testing Market Size by Country (2019-2024)
9.4 Latin America Viral Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Viral Testing Market Size (2019-2030)
10.2 Middle East & Africa Viral Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Viral Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Viral Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Viral Testing Introduction
11.1.4 Roche Revenue in Viral Testing Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Viral Testing Introduction
11.2.4 Agilent Technologies Revenue in Viral Testing Business (2019-2024)
11.2.5 Agilent Technologies Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Viral Testing Introduction
11.3.4 Thermo Fisher Scientific Revenue in Viral Testing Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 QIAGEN International
11.4.1 QIAGEN International Company Detail
11.4.2 QIAGEN International Business Overview
11.4.3 QIAGEN International Viral Testing Introduction
11.4.4 QIAGEN International Revenue in Viral Testing Business (2019-2024)
11.4.5 QIAGEN International Recent Development
11.5 Lonza
11.5.1 Lonza Company Detail
11.5.2 Lonza Business Overview
11.5.3 Lonza Viral Testing Introduction
11.5.4 Lonza Revenue in Viral Testing Business (2019-2024)
11.5.5 Lonza Recent Development
11.6 Wuxi Pharmatech (Cayman)
11.6.1 Wuxi Pharmatech (Cayman) Company Detail
11.6.2 Wuxi Pharmatech (Cayman) Business Overview
11.6.3 Wuxi Pharmatech (Cayman) Viral Testing Introduction
11.6.4 Wuxi Pharmatech (Cayman) Revenue in Viral Testing Business (2019-2024)
11.6.5 Wuxi Pharmatech (Cayman) Recent Development
11.7 Merck
11.7.1 Merck Company Detail
11.7.2 Merck Business Overview
11.7.3 Merck Viral Testing Introduction
11.7.4 Merck Revenue in Viral Testing Business (2019-2024)
11.7.5 Merck Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Detail
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific Viral Testing Introduction
11.8.4 Eurofins Scientific Revenue in Viral Testing Business (2019-2024)
11.8.5 Eurofins Scientific Recent Development
11.9 General Electric
11.9.1 General Electric Company Detail
11.9.2 General Electric Business Overview
11.9.3 General Electric Viral Testing Introduction
11.9.4 General Electric Revenue in Viral Testing Business (2019-2024)
11.9.5 General Electric Recent Development
11.10 Danaher
11.10.1 Danaher Company Detail
11.10.2 Danaher Business Overview
11.10.3 Danaher Viral Testing Introduction
11.10.4 Danaher Revenue in Viral Testing Business (2019-2024)
11.10.5 Danaher Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Viral Testing Introduction
11.11.4 Bio-Rad Laboratories Revenue in Viral Testing Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 BD
11.12.1 BD Company Detail
11.12.2 BD Business Overview
11.12.3 BD Viral Testing Introduction
11.12.4 BD Revenue in Viral Testing Business (2019-2024)
11.12.5 BD Recent Development
11.13 Biospherix
11.13.1 Biospherix Company Detail
11.13.2 Biospherix Business Overview
11.13.3 Biospherix Viral Testing Introduction
11.13.4 Biospherix Revenue in Viral Testing Business (2019-2024)
11.13.5 Biospherix Recent Development
11.14 Novogene Corporation
11.14.1 Novogene Corporation Company Detail
11.14.2 Novogene Corporation Business Overview
11.14.3 Novogene Corporation Viral Testing Introduction
11.14.4 Novogene Corporation Revenue in Viral Testing Business (2019-2024)
11.14.5 Novogene Corporation Recent Development
11.15 Sartorius
11.15.1 Sartorius Company Detail
11.15.2 Sartorius Business Overview
11.15.3 Sartorius Viral Testing Introduction
11.15.4 Sartorius Revenue in Viral Testing Business (2019-2024)
11.15.5 Sartorius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Viral Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Direct Fluorescent Antibody (DFA) Test
Table 3. Key Players of Immunochromatographic Assay
Table 4. Key Players of RT-PCR-Based Test
Table 5. Key Players of Agglutination Assay
Table 6. Key Players of Flow-Through Assay
Table 7. Key Players of Solid-Phase Assay
Table 8. Global Viral Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Viral Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Viral Testing Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Viral Testing Market Share by Region (2019-2024)
Table 12. Global Viral Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Viral Testing Market Share by Region (2025-2030)
Table 14. Viral Testing Market Trends
Table 15. Viral Testing Market Drivers
Table 16. Viral Testing Market Challenges
Table 17. Viral Testing Market Restraints
Table 18. Global Viral Testing Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Viral Testing Market Share by Players (2019-2024)
Table 20. Global Top Viral Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Testing as of 2023)
Table 21. Ranking of Global Top Viral Testing Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Viral Testing Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Viral Testing Product Solution and Service
Table 25. Date of Enter into Viral Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Viral Testing Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Viral Testing Revenue Market Share by Type (2019-2024)
Table 29. Global Viral Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Viral Testing Revenue Market Share by Type (2025-2030)
Table 31. Global Viral Testing Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Viral Testing Revenue Market Share by Application (2019-2024)
Table 33. Global Viral Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Viral Testing Revenue Market Share by Application (2025-2030)
Table 35. North America Viral Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Viral Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Viral Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Viral Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Viral Testing Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Viral Testing Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Viral Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Viral Testing Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Viral Testing Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Viral Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Viral Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Viral Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Viral Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Viral Testing Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Viral Testing Market Size by Country (2025-2030) & (US$ Million)
Table 50. Roche Company Detail
Table 51. Roche Business Overview
Table 52. Roche Viral Testing Product
Table 53. Roche Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 54. Roche Recent Development
Table 55. Agilent Technologies Company Detail
Table 56. Agilent Technologies Business Overview
Table 57. Agilent Technologies Viral Testing Product
Table 58. Agilent Technologies Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 59. Agilent Technologies Recent Development
Table 60. Thermo Fisher Scientific Company Detail
Table 61. Thermo Fisher Scientific Business Overview
Table 62. Thermo Fisher Scientific Viral Testing Product
Table 63. Thermo Fisher Scientific Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 64. Thermo Fisher Scientific Recent Development
Table 65. QIAGEN International Company Detail
Table 66. QIAGEN International Business Overview
Table 67. QIAGEN International Viral Testing Product
Table 68. QIAGEN International Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 69. QIAGEN International Recent Development
Table 70. Lonza Company Detail
Table 71. Lonza Business Overview
Table 72. Lonza Viral Testing Product
Table 73. Lonza Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 74. Lonza Recent Development
Table 75. Wuxi Pharmatech (Cayman) Company Detail
Table 76. Wuxi Pharmatech (Cayman) Business Overview
Table 77. Wuxi Pharmatech (Cayman) Viral Testing Product
Table 78. Wuxi Pharmatech (Cayman) Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 79. Wuxi Pharmatech (Cayman) Recent Development
Table 80. Merck Company Detail
Table 81. Merck Business Overview
Table 82. Merck Viral Testing Product
Table 83. Merck Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Eurofins Scientific Company Detail
Table 86. Eurofins Scientific Business Overview
Table 87. Eurofins Scientific Viral Testing Product
Table 88. Eurofins Scientific Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 89. Eurofins Scientific Recent Development
Table 90. General Electric Company Detail
Table 91. General Electric Business Overview
Table 92. General Electric Viral Testing Product
Table 93. General Electric Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 94. General Electric Recent Development
Table 95. Danaher Company Detail
Table 96. Danaher Business Overview
Table 97. Danaher Viral Testing Product
Table 98. Danaher Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 99. Danaher Recent Development
Table 100. Bio-Rad Laboratories Company Detail
Table 101. Bio-Rad Laboratories Business Overview
Table 102. Bio-Rad Laboratories Viral Testing Product
Table 103. Bio-Rad Laboratories Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 104. Bio-Rad Laboratories Recent Development
Table 105. BD Company Detail
Table 106. BD Business Overview
Table 107. BD Viral Testing Product
Table 108. BD Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 109. BD Recent Development
Table 110. Biospherix Company Detail
Table 111. Biospherix Business Overview
Table 112. Biospherix Viral Testing Product
Table 113. Biospherix Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 114. Biospherix Recent Development
Table 115. Novogene Corporation Company Detail
Table 116. Novogene Corporation Business Overview
Table 117. Novogene Corporation Viral Testing Product
Table 118. Novogene Corporation Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 119. Novogene Corporation Recent Development
Table 120. Sartorius Company Detail
Table 121. Sartorius Business Overview
Table 122. Sartorius Viral Testing Product
Table 123. Sartorius Revenue in Viral Testing Business (2019-2024) & (US$ Million)
Table 124. Sartorius Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Viral Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Viral Testing Market Share by Type: 2023 VS 2030
Figure 3. Direct Fluorescent Antibody (DFA) Test Features
Figure 4. Immunochromatographic Assay Features
Figure 5. RT-PCR-Based Test Features
Figure 6. Agglutination Assay Features
Figure 7. Flow-Through Assay Features
Figure 8. Solid-Phase Assay Features
Figure 9. Global Viral Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Viral Testing Market Share by Application: 2023 VS 2030
Figure 11. Laboratory Case Studies
Figure 12. Hospital Case Studies
Figure 13. Home Care Case Studies
Figure 14. Academic Institute Case Studies
Figure 15. Viral Testing Report Years Considered
Figure 16. Global Viral Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Viral Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Viral Testing Market Share by Region: 2023 VS 2030
Figure 19. Global Viral Testing Market Share by Players in 2023
Figure 20. Global Top Viral Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Testing as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Viral Testing Revenue in 2023
Figure 22. North America Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Viral Testing Market Share by Country (2019-2030)
Figure 24. United States Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Viral Testing Market Share by Country (2019-2030)
Figure 28. Germany Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Viral Testing Market Share by Region (2019-2030)
Figure 36. China Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Viral Testing Market Share by Country (2019-2030)
Figure 44. Mexico Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Viral Testing Market Share by Country (2019-2030)
Figure 48. Turkey Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Viral Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Roche Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 51. Agilent Technologies Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 53. QIAGEN International Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 54. Lonza Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 55. Wuxi Pharmatech (Cayman) Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 56. Merck Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 57. Eurofins Scientific Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 58. General Electric Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 59. Danaher Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 61. BD Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 62. Biospherix Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 63. Novogene Corporation Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 64. Sartorius Revenue Growth Rate in Viral Testing Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
